Gastrointestinal surgery is a procedure for diseases of the areas of the body that are involved in digestion. This includes the esophagus, liver, small intestine, large intestine, and rectum. It involves the liver, gallbladder, and pancreas as well. Surgery can be used to remove cancerous or non-cancer growth or damaged parts of the body, such as the intestine.
Below are gastrointestinal disorders that can be treated with surgery:
Appendicitis, Colon cancers and other stomach cancers, Diverticular illness, Disease of the gallbladder, Gastroesophageal reflux disease (GERD) and hiatal hernia, Inflammatory intestinal disorder, Rectoral prolapse, and Loss of weight
A surgical technique called an endoscopy is used to screen and diagnose conditions in the digestive system. The doctor puts a long, thin tube with a tiny camera in the body to see inside.
Options for General Intestinal Surgery
• Endoscopic Surgery
• Laparoscopic Surgery
• Robotic surgery
Minimally Invasive GI Surgical Procedures
Listed below are some types of laparoscopic procedures that are done to treat GI conditions:
Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hiatal Hernia Repair, Nissen, Nephrectomy, Pancreatic Surgery, Retroperitoneum Surgery, and Splenectomy
Open GI Surgical Procedures
Abdominal Surgery, Adrenalectomy, Appendectomy, Nissen fundoplication, Roux-en-Y and Whipple Procedure
Recovery time will depend on the surgery and how invasive it is. With a few quick surgeries, including a colonoscopy, you can get back to your everyday activities right away. With more invasive surgery, you will need some time to recover, and some help with post-operative pain control.
In 2020, the global gastrointestinal stents market will be worth US$ 402.5 million. The market is expected to develop at a CAGR of 3.6% between 2021 and 2026, according to IMARC Group.
In 2025, the global market for robotic gastrointestinal surgery will reach $1.41 billion.
The global market for minimally invasive gastrointestinal surgical systems was valued at $5,021.8 million in 2020 and is expected to reach $10,441.0 million by 2031, rising at a CAGR of 6.8% from 2021 to 2031.
ALSO READ Clinical Gastroenterology Gastroenterology Treatment Advances in Gastroenterology Gallbladder and Biliary Disease Gastrointestinal Complications in Pregnancy Gastrointestinal Disorders Gastrointestinal Pathology Gastrointestinal Pharmacotherapy Gastrointestinal Cancer Gastrointestinal Radiology Gastrointestinal Surgery Inflammatory Bowel Disease Pediatric Gastroenterology Pancreatic and Biliary Disease Bariatric Surgery Colorectal Oncology Endoscopy and Hepatology Esophageal and Gastric Disease Pancreatic Diseases Gastro Esophageal Reflux Disease Gastrointestinal Immunology Digestive Diseases Liver Diseases Gastroenterologist Celiac Disease Hepatitis B Barretts Esophagus Crohn Disease Cirrhosis Hepatitis C Liver and Intestine Transplant Kidney and Pancreas Transplant Peptic Ulcer Disease GI Bleeding GI Infectious Disease Gastroenterologists
Hepatology Conferences Hepatitis Conferences Pancreas Conferences Liver and Intestine Conferences Gastrointestinal Surgery Conferences Gastrointestinal Disease Conferences Peptic ulcer Disease Conferences Gastroenterology Conferences 2022 Asia Gastroenterology Conferences 2022 Europe Gastroenterology Conferences Biliary Bowl Disease Conferences Biriatic Surgery Conferences Kidney Disease Conferences Pancreas Conferences 2022 Asia Liver Disease Conferences